目的 探讨使用生物型非骨水泥假体治疗髋臼内陷症的近期疗效。 方法 2007年6月－2010年5月，对11例12髋髋臼内陷患者行生物型假体全髋关节置换术。男2例，女9例；年龄38～57岁，平均47.3岁。其中继发于类风湿性关节炎7例，创伤4例；病程1～18年，平均8.9年；轻度髋臼内陷6髋，中度髋臼内陷6髋。采用Harris评分标准进行临床疗效评估，摄X线片进行影像学评估。 结果 术后第2天X线片示，人工股骨头距Kohler’s线外移（1.42 ± 2.27）mm，较术前股骨头内陷（?5.17 ± 2.04）mm明显改善（P＜0.05）。术后1周，患者Harris评分为（85.75 ± 4.73）分，较术前（39.75 ± 5.24）分显著提高（P＜0.05）。术后1年X线片示髋臼假体与髋臼内侧壁无透亮线，已骨融合。术后患者获随访2～5年。髋臼假体均无松动移位、脱位或移植骨的吸收。 结论 使用生物型非骨水泥假体结合自体骨移植治疗髋臼内陷症，能有效恢复髋臼运动中心的解剖位置，近期临床疗效满意。
Objective To explore the clinical efficacy and safety of percutaneous kyphoplasty (PKP) in the treatment of Kummell disease. Methods We retrospectively analyzed the clinical data of 11 patients with Kummell disease treated by PKP between January 2013 and January 2016. There were 8 males and 3 females with an average age of 72.3 years old ranging from 64 to 78. The injured vertebra was located at T11 in 2 patients, T12 in 3, and L1 in 6. All the patients suffered from lower back pain for 2.5-15.0 months averaging 7.6 months. Preoperative CT and MRI examinations showed that there were clear signs of intravertebral vacuum cleft and abnormal fluid signals. The Visual Analogue Scale (VAS), Oswestry Disability Index (ODI), and the height and kyphotic angle of the injured vertebral body were measured to evaluate the clinical outcomes before and after surgery. Results Follow-up was conducted for all 11 patients. Cement leakage occurred in 4 patients with no symptoms. The vertebral height, Cobb angel of the injured vertebra, VAS and ODI improved significantly after surgery and during the latest follow-up. Compared with those parameters after surgery, only VAS score was different during the latest follow-up. Conclusion PKP is safe and effective in the treatment of Kummell disease.